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ilizing immune responses. ML29 is a promissing vaccine to
control LF in West Africa.
doi:10.1016/j.ijid.2008.05.684
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Burkholderia pseudomallei is the etiological agent of
melioidosis, a severe invasive disease of humans and ani-
mals in subtropical areas and northern Australia. There is
an urgent need to develop effective therapeutic molecules
against the pathogen for better management of melioidosis.
We undertook to survey for all potential B. pseudoma-
llei immunogenic proteins in order to dissect the bacterial
pathogenesis and evaluate vaccine candidates. In the
present study, a B. pseudomallei clinical isolate (D286)
genomic expression library was constructed and 109 sero-
reactive clones were identiﬁed from the library screened
with pooled melioidosis patients’ sera. DNA sequence
analysis of the seropositive clones revealed 109 putative
immunogenic proteins that were annotated and delin-
eated into functional classes of cell envelope components,
protein secretion and cell motility, transcription, amino
acid transport and metabolism, inorganic ion transport
and metabolism, energy production, protein metabolism,
nucleic acid metabolism and repair, unknown function hypo-
thetical proteins, and other metabolism and transporter
proteins. The complete open reading frame of an immuno-
genic putative outer membrane protein (Oma) was cloned,
expressed and shown to maintain immuno-reactivity with
patient sera. Up to 80% of BALB/c mice immunized with
recombinant Oma were protected from infectious chal-
lenge with 10xLD50 of B. pseudomallei D286, compared with
non-immunized mouse. Therefore, the utility of Oma as a
potential prophylactic agent for melioidosis is proposed.
Mouse anti-Oma polyclonal serum conﬁrmed the presence of
wild type Oma in B. pseudomallei lysate. In addition, pro-
tein sequence analysis revealed that Oma is a member of the
Omp85 family and is highly conserved among species within
the Burkholderia genus, suggesting its suitability as a univer-
sal vaccine candidate or diagnostic epitope for Burkholderia
spp. Characterization of the B. pseudomallei immunome has
shed new light on unraveling the bacterium’s pathogenic
mechanism and disease severity. These immunogens can be
further evaluated as vaccine and serodiagnostic candidates
as well as drug targets.
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Background: It is known that the attenuated polio vac-
cine viruses derived from oral poliovirus vaccine undergo
neurovirulent reversion during repeated replication in the
human alimentary tract, and some paralytic cases caused by
the revertants have been reported. Furthermore, the rever-
tants are excreted with the feces into the environment, and
the viruses have caused new epidemics of poliomyelitis in
the world. It is an obstacle for the achievement of polio
eradication program.
Objective: In this study, to elucidate the reversion mech-
anism of polio vaccine virus to the neurovirulent genotype in
the human alimentary tract, an accumulation of the rever-
sion of the vaccine viruses passaged in cultivation cells which
were derived from the human alimentary tract was ana-
lyzed.
Methods: Polio vaccine viruses were passaged three times
in Caco-2 cells derived from human colon carcinoma. The
reversion of the passaged viruses was analyzed by the
‘‘mutant analysis by PCR and restriction enzyme cleavage
(MAPREC)’’ method designated to estimate the ratio of
revertants in a virus population.
Results: The accumulation of reversion in the vaccine
viruses increased rapidly with viruses passaged at a tem-
perature of 37 ◦C compared with those at 34 ◦C. However,
it was hardly observed in viruses passaged in HEp-2 cells
which were derived from human laryngeal carcinoma at a
temperature of 37 ◦C.
Conclusion: A large difference was observed in the fre-
quency of reversion between Caco-2 and HEp-2 cells though
both cells were derived from human carcinoma. It is impor-
tant to elucidate the cellular factors which take part in the
reversion frequency of the virus genome. Such research is
expected to lead to the elucidation of the reversion mecha-
nism and to the development of a controlling expedient for
the neurovirulent reversion of the polio vaccine virus.
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Current egg-based inﬂuenza vaccine production technol-
ogy is labor-intensive and lack of ﬂexibility and its capacity
would not be able to meet the demand during inﬂuenza
pandemics. Therefore, vaccine production using mammalian
cell technology is becoming viable and attractive. The cur-
rent inﬂuenza H5N1 vaccine strain (NIBRG-14) could grow
efﬁciently in chicken embroyonated eggs and MDCK cells
